RT Journal Article
SR Electronic
T1 A Sustainable Development Goal framework to guide multisectoral action on NAFLD through a societal approach
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.02.21261464
DO 10.1101/2021.08.02.21261464
A1 Lazarus, Jeffrey V
A1 Mark, Henry E
A1 Colombo, Massimo
A1 Demaio, Sandro
A1 Dillon, John F
A1 George, Jacob
A1 Hagström, Hannes
A1 Hocking, Samantha
A1 Lee, Nancy
A1 Nieuwenhuijsen, Mark J
A1 Rinella, Mary E
A1 Romero-Gomez, Manuel
A1 Soriano, Joan B
A1 Schattenberg, Jörn M
A1 Tacke, Frank
A1 Tsochatzis, Emmanuel A.
A1 Valenti, Luca
A1 Zelber-Sagi, Shira
A1 Dirac, M. Ashworth
A1 Huang, Terry T-K
YR 2021
UL http://medrxiv.org/content/early/2021/08/04/2021.08.02.21261464.abstract
AB Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition that requires a comprehensive and coordinated response across sectors and disciplines. In the absence of a multisectoral framework, we developed a NAFLD-Sustainable Development Goals (SDG) framework to converge thinking about the design and delivery of NAFLD public health responses. A multidisciplinary group identified SDG targets and indicators for inclusion in the NAFLD-SDG framework through a two-stage process. Firstly, a core team of three researchers independently reviewed the 169 SDG targets and 231 unique indicators proposed by the Inter-Agency and Expert Group on SDG to select a shortlist. Over two Delphi rounds, a multidisciplinary group of 12 experts selected which of the shortlisted targets and indicators to include in the NAFLD-SDG framework. Respondents also provided written feedback on their selection. Targets and indicators with 75% or greater agreement were included in the final NAFLD-SDG framework. The final framework comprises 16 targets–representing 9% of all SDG targets and 62% (16/26) of the shortlisted targets–and seven indicators, accounting for 50% (7/14) of the shortlisted indicators and 3% of all SDG indicators. The selected targets and indicators cover a broad range of factors, from health, food and nutrition to education, the economy and the built environment. Addressing the challenge of NAFLD will require re-envisioning the liver health landscape, with a greater focus on joined-up systems thinking and action. The NAFLD-SDG framework can help guide this process, including by outlining the key stakeholders with whom the liver health community needs to engage.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the EASL International Liver Foundation who acknowledges funding from Intercept Pharmaceutics, as well as Bristol Myers Squibb and Merck Sharp & Dohme. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from the corresponding author upon request.